Welcome to the Evidence Hub

Carolyn Magill
,
CEO, Aetion

Welcome to the Evidence Hub, an ongoing conversation about perspectives, milestones, and best practices in applying real-world evidence in life sciences and value-based health care. Here is where we share our thinking—and invite your thinking—about one of the most powerful levers we have to fix health care: data.

Read more

FDA Decision Alerts

Our FDA Decision Alerts summarize examples in which RWE was included in the submission package for new drugs and biologics.

The Evidence Digest

Subscribe to our newsletter for insights and updates on real-world evidence research and applications.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
September 16, 2020
fit for purpose
decision-making
jmdc
ICPE research spotlight: Part I: Expanding real-world applications of RWE
July 30, 2020
FDA
infectious disease
fda decisions
Lessons from four recent FDA decisions in infectious disease
Christina Purpura
Ray Harvey
June 25, 2020
FDA
HTA
regulatory
The case for regulator-HTA collaboration on RWE methodology standards
Ashley Jaksa, M.P.H.
June 4, 2020
target trial
decision-making
RCT DUPLICATE
The causal revolution in observational research: Breaking the causality taboo
Jeremy Rassen, Sc.D.
May 21, 2020
coronavirus
covid-19
decision-making
COVID-19: The critical role of real-world evidence made real
Carolyn Magill
May 14, 2020
coronavirus
covid-19
Methods
COVID-19, a look ahead: Common self-controlled study designs used in vaccine safety
Pattra Mattox, S.M., C.M.P.P.
Mandy Patrick, M.S.
May 8, 2020
HTA
health technology assessment
standards
HTAs and RWE: Current use, predicted trends, and next steps for biopharma
Ashley Jaksa, M.P.H.
April 23, 2020
covid-19
coronavirus
real-world evidence
Real-world evidence and COVID-19: Empower rapid, reliable, data science-driven decisions
Liz DeMatteis
Abby Stockwell
April 21, 2020
decision-making
FDA
real-world evidence
The surge in FDA approvals supported by RWE: A look at three recent FDA decisions
Christina Purpura
March 27, 2020
covid-19
coronavirus
real-world evidence
How to plan for evidence generation in a time of uncertainty
Carolyn Magill
February 6, 2020
telemedicine
wearable
summit
How emerging technologies will ensure increasing availability of RWD
Yin Ho, M.D., M.B.A.
January 30, 2020
Insights
Contextual considerations in RWE generation and use
Ashley Jaksa, M.P.H.
December 19, 2019
health technology assessment
HTA
decision-making
Let’s talk about value: How biopharma can maximize utility of RWE in value discussions
Ashley Jaksa, M.P.H.
December 6, 2019
summit
oncology
standards
Advancing cancer care with real-world data: Next steps for collaborators
Brittany Ryan
November 22, 2019
summit
FDA
decision-making
Evidence at the Apex: Five learnings from the first annual Aetion Summit
Carolyn Magill
November 14, 2019
Event recaps
Insights
Spotlight on trust and transparency at ISPOR Europe 2019
Ashley Jaksa, M.P.H.
October 11, 2019
Insights
The case for real-world evidence in health technology assessment
Ashley Jaksa, M.P.H.
September 26, 2019
real-world evidence
CPT
Everyone in the pool: How diverse stakeholders speed RWE adoption
Jocelyn Wang, M.S.
September 20, 2019
ICPE
ISPE
decision-making
Takeaways from the 35th ICPE
Olivia Rybolt
August 20, 2019
germany
HTA
health technology assessment
The case for real-world evidence in Germany
Ashley Jaksa, M.P.H.
June 25, 2019
FDA
decision-making
RCT DUPLICATE
Predicting the CAROLINA trial with real-world evidence: Three takeaways for pharma
Kristen Deken, M.B.A.
Jeremy Rassen, Sc.D.
June 14, 2019
pfizer
patient
Insights
Addressing the determinants of health: What is pharma’s role?
Gale Pryor
May 31, 2019
HTA
health technology assessment
canada
Health Canada moves to adopt real-world evidence
Ashley Jaksa, M.P.H.
May 24, 2019
ISPOR
FDA
transparency
Four takeaways from ISPOR 2019
Ashley Jaksa, M.P.H.
April 26, 2019
data
technology
wearable
Future sources of real-world data: Opportunities and challenges
William Murk, Ph.D., M.P.H.
April 12, 2019
real-world evidence
learn
regulatory
Readings in real-world evidence: A round up of essential sources of information
Olivia Rybolt
March 15, 2019
Methods
transparency
fit for purpose
Why does data traceability matter—and how do platforms help?
Jeremy Rassen, Sc.D.
March 1, 2019
Methods
The perils of immortal time bias
Sruthi Adimadhyam, Ph.D.
February 22, 2019
FDA
decision-making
regulatory
The epidemiology of databases: Part II: Four principles of generating real-world evidence
Jeremy Rassen, Sc.D.
February 15, 2019
Methods
Insights
The epidemiology of databases: Part I: Four principles of working with real-world data
Natalia Petruski-Ivleva, Ph.D.
January 31, 2019
trends
real-world evidence
technology
A year of acceleration: Looking ahead at 2019
Bill Geary
January 31, 2019
data
decision-making
Four questions to ask your data
William Murk, Ph.D., M.P.H.
©2020 Aetion, Inc.      Terms of Use      Privacy Policy      Patents